Lilia Mercedes Sierra-Galan

Dr. Lilia Mercedes Sierra-Galan

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2021 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
HMHector I Michelena
Hector I Michelena
Alessandro Della CorteAlessandro Della Corte
Alessandro Della Corte
AEArturo Evangelista
Arturo Evangelista
JMJoseph J Maleszewski
Joseph J Maleszewski
WEWilliam D Edwards
William D Edwards
HSHans-Joachim Schäfers
Hans-Joachim Schäfers
This International Consensus Classification and Nomenclature for the congenital bicuspid aortic valve condition recognizes 3 types of bicuspid valves: 1. The fused type (right-left cusp fusion, right-non-coronary cusp fusion and left-non-coronary cusp fusion phenotypes); 2. The 2-sinus type (latero-lateral and antero-posterior phenotypes); and 3. The partial-fusion (forme fruste) type. The presence of raphe and the symmetry of the fused type phenotypes are critical aspects to describe. The International Consensus also recognizes 3 types of bicuspid valve-associated aortopathy: 1. The ascending phenotype; 2. The root phenotype; and 3. Extended phenotypes.

1 September 2021 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
HMHector I. Michelena
Hector I. Michelena
Alessandro Della CorteAlessandro Della Corte
Alessandro Della Corte
AEArturo Evangelista
Arturo Evangelista
JMJoseph J. Maleszewski
Joseph J. Maleszewski
WEWilliam D. Edwards
William D. Edwards
HSHans-Joachim Schäfers
Hans-Joachim Schäfers

9 July 2022 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
Sophie I. MavrogeniSophie I. Mavrogeni
Sophie I. Mavrogeni
Alessia PepeAlessia Pepe
Alessia Pepe
RNR Nijveldt
R Nijveldt
NNNtobeko Ntusi
Ntobeko Ntusi
LSLilia Mercedes Sierra-Galan
Lilia Mercedes Sierra-Galan
BCBernard Cosyns
Bernard Cosyns
Autoimmune rheumatic diseases (ARDs) involve multiple organs including the heart and vasculature. Despite novel treatments, patients with ARDs still experience a reduced life expectancy, partly caused by the higher prevalence of cardiovascular disease (CVD). This includes CV inflammation, rhythm disturbances, perfusion abnormalities (ischaemia/infarction), dysregulation of vasoreactivity, myocardial fibrosis, coagulation abnormalities, pulmonary hypertension, valvular disease, and side-effects of immunomodulatory therapy. Currently, the evaluation of CV involvement in patients with ARDs is based on the assessment of cardiac symptoms, coupled with electrocardiography, blood testing, and echocardiography. However, CVD may not become overt until late in the course of the disease, thus potentially limiting the therapeutic window for intervention. More recently, cardiovascular magnetic resonance (CMR) has allowed for the early identification of pathophysiologic structural/functional alterations that take place before the onset of clinically overt CVD. CMR allows for detailed evaluation of biventricular function together with tissue characterization of vessels/myocardium in the same examination, yielding a reliable assessment of disease activity that might not be mirrored by blood biomarkers and other imaging modalities. Therefore, CMR provides diagnostic information that enables timely clinical decision-making and facilitates the tailoring of treatment to individual patients. Here we review the role of CMR in the early and accurate diagnosis of CVD in patients with ARDs compared with other non-invasive imaging modalities. Furthermore, we present a consensus-based decision algorithm for when a CMR study could be considered in patients with ARDs, together with a standardized study protocol. Lastly, we discuss the clinical implications of findings from a CMR examination.

1 September 2021 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
HMHector I. Michelena
Hector I. Michelena
Alessandro Della CorteAlessandro Della Corte
Alessandro Della Corte
AEArturo Evangelista
Arturo Evangelista
JMJoseph J. Maleszewski
Joseph J. Maleszewski
WEWilliam D. Edwards
William D. Edwards
HSHans-Joachim Schäfers
Hans-Joachim Schäfers

1 August 2021 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
HMHector I. Michelena
Hector I. Michelena
Alessandro Della CorteAlessandro Della Corte
Alessandro Della Corte
AEArturo Evangelista
Arturo Evangelista
JMJoseph J. Maleszewski
Joseph J. Maleszewski
WEWilliam D. Edwards
William D. Edwards
HSHans-Joachim Schäfers
Hans-Joachim Schäfers
This international evidence-based nomenclature and classification consensus on the congenital bicuspid aortic valve is intended to be universally used by clinicians, echocardiography sonographers a... This International Consensus Classification and Nomenclature for the congenital bicuspid aortic valve condition recognizes 3 types of bicuspid valves: 1. The fused type (right-left cusp fusion, rig...

Verified
Journal Article
Open access
PDF file
JDJustin Albert Daneshrad
Justin Albert Daneshrad
KOKaren Ordovas
Karen Ordovas
LSLilia Mercedes Sierra-Galan
Lilia Mercedes Sierra-Galan
AHAllison G. Hays
Allison G. Hays
MMMamas A. Mamas
Mamas A. Mamas
PPPurvi Parwani
Purvi Parwani
Myocardial infarction with Non Obstructive Coronary Arteries (MINOCA) is defined by patients presenting with signs and symptoms similar to acute myocardial infarction, but are found to have non-obstructive coronary arteries angiography. What was once considered a benign phenomenon, MINOCA has been proven to carry with it significant morbidity and worse mortality when compared to the general population. As the awareness for MINOCA has increased, guidelines have focused on this unique situation. Cardiac magnetic resonance (CMR) has proven to be an essential first step in the diagnosis of patients with suspected MINOCA. CMR has also been shown to be crucial when differentiating between MINOCA like presentations such as myocarditis, takotsubo and other forms of cardiomyopathy. The following review focuses on demographics of patients with MINOCA, their unique clinical presentation as well as the role of CMR in the evaluation of MINOCA.